Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
BioSante
LibiGel
testosterone
EntreMed
ENMD-2076
cancer
Protalix BioTherapeutics
UPLYSO
ovarian cancer
Vivus
Qnexa
obesity
EMD 640744
cancer vaccines
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tue, 07/13/10 - 11:14 am
obsesity
diet drugs
advisory panels
FDA
Qnexa
Vivus
Arena Pharmaceuticals
Contrave
Orexigen
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tue, 07/13/10 - 08:43 am
FDA
diet drugs
obesity
Vivus
advisory panels
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Mon, 07/12/10 - 02:39 pm
FDA
Vivus
obesity
Qnexa
Orexigen
Arena Pharmaceuticals
Contrave
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
WSJ Online
Mon, 07/12/10 - 10:24 am
Qnexa
Avandia
FDA
GSK
diabetes
obesity
advisory panels
Vivus
Rodman & Renshaw lowers Vivus to 'Market Perform'
Yahoo/AP
Sat, 07/10/10 - 11:18 am
obesity
Qnexa
Vivus
Onyx, Vivus rise on ratings boost
MarketWatch
Sat, 07/10/10 - 11:12 am
ONYX Pharmaceuticals
Vivus
Biotech Stock Mailbag: Somaxon
TheStreet.com
Fri, 07/9/10 - 12:27 pm
Somaxon
Dendreon
Arena Pharmaceuticals
Orexigen
Vivus
Roche
GSK
Immunogen
How to Trade on an FDA Advisory Panel
Minyanville
Fri, 07/9/10 - 11:38 am
FDA
advisory panels
Qnexa
Arena Pharmaceuticals
Vivus
Orexigen
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Sat, 06/26/10 - 09:17 am
obesity
Orexigen
Qnexa
Vivus
Abbott Laboratories
GSK
Meridia
Alli
The Skinny on the Qnexa FDA Advisory Meeting
Minyanville
Thu, 06/24/10 - 02:55 pm
FDA
Qnexa
obesity
Vivus
advisory panels
Buy Vivus Bullish Options Before Review of Obesity Drug, JPMorgan Advises
Bloomberg
Wed, 06/23/10 - 10:57 am
Vivus
obesity
There Is Life After Death, At Least In Biotech
Investopedia
Tue, 06/22/10 - 10:35 am
biotech
Celgene
Genzyme
Gilead Sciences
Isis Pharmaceuticals
Vivus
Neurocrine
Nektar
Will the Obesity Epidemic Spur a New ED Pill Just for Diabetics? One Drug Company Seems to Think So
BNET Pharma
Wed, 06/9/10 - 09:15 am
Vivus
obesity
diabetes
Avanafil
erectile dysfunction
Vivus says erectile dysfunction drug meets goals
Yahoo/AP
Mon, 06/7/10 - 10:53 am
erectile dysfunction
Vivus
Avanafil
diabetes
Drug stocks end dismal May with another loss
MarketWatch
Sat, 05/29/10 - 09:21 am
Cubist Pharmaceuticals
Vivus
Arca pharmaceutical index
The race to discover Viagra for women
The Guardian, UK
Sun, 04/25/10 - 11:32 am
Vivus
Alista
female sexual dysfunction
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
obesity
Vivus
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
14 Biotech Stocks Facing FDA Approval
TheStreet.com
Wed, 04/7/10 - 10:01 am
Cell Therapeutics
Pozen
AstraZeneca
Dendreon
InterMune
Questcor Pharmaceuticals
Novartis
Biogen Idec
Teva Pharmaceuticals
Merck Serono
Savient
Javelin
Alexza
Human Genome
Jazz Pharmaceuticals
Arena Pharmaceuticals
Vivus
Biodel
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
next ›
last »